查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869678

栓塞治療市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2025-2033 年）

Embolotherapy Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

栓塞市場摘要

2024年全球栓塞治療市場規模估計為31.6億美元，預計2033年將達到58.2億美元。

預計從 2025 年到 2033 年，該市場將以 6.99% 的複合年成長率成長。該市場的主要成長要素是癌症、血管疾病和創傷病例的增加，這些因素推動了對微創治療方法的需求。

栓塞劑（如藥物釋放型珠、液體栓塞劑和生物可吸收微球）的技術進步，以及創新輸送裝置（如微導管和血流導向裝置）的出現，提高了手術的精確性、安全性和臨床療效。

此外，患者越來越傾向於選擇恢復時間更短的微創手術，新興市場醫療基礎設施不斷擴大，以及有利的法規結構，這些因素共同推動了微創手術的進一步普及，為持續成長創造了機會，並鞏固了市場的上升趨勢。

全球癌症治療、創傷病例和血管疾病的增加推動了對先進栓塞解決方案的需求。醫院、診所和介入放射中心的手術量不斷成長，對高效栓塞劑和輸送系統的需求也隨之持續增加。這一趨勢進一步促使醫療機構採用創新、微創的技術，在確保安全性和效率的同時改善患者預後。為了滿足這些需求，醫療機構正在加速向下一代栓塞技術轉型，以實現更快的手術速度、更高的精準度和更少的併發症。

例如，2025年6月，Penumbra公司宣布推出Ruby XL系統，這是目前市場上最長、最大、最靈活的栓塞系統，並已獲得美國食品藥物管理局（FDA）的核准。 Ruby XL系統旨在幫助醫生更有效率地進行栓塞手術，從而可能減少輻射曝射量並改善治療效果，尤其是在涉及大血管或高流量栓塞的手術中。

癌症和血管疾病發生率的上升是栓塞治療產業的主要驅動力，因為這些疾病通常需要標靶性、微創治療來控制出血、縮小腫瘤體積或處理異常血管。肝癌患者經常接受經動脈栓塞術，以阻斷腫瘤的血液供應並減緩腫瘤生長，同時保護周圍健康組織。由於恢復時間短、併發症少，栓塞術也擴大被用作動靜脈畸形和消化道出血等疾病的有效替代開放性手術。根據世界衛生組織估計，2022年至2040年間，男性和女性（0-85歲及以上）肝癌和肝內膽管癌的新病例數預計將會增加。詳情請見下方資料框和圖表。

目錄

第1章調查方法和範圍

第2章執行摘要

3.栓塞治療市場變數、趨勢和範圍

  • 市場體系展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 栓塞治療市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 栓塞治療市場：依產品分類的估計與趨勢分析

  • 細分儀表板
  • 產品差異分析及市佔率（2024 年及 2033 年）
  • 栓塞線圈
  • 栓塞劑
    • 分流器
    • 可拆卸氣球
    • 血管栓塞器/栓塞系統
    • 支援的設備

第5章 栓塞治療市場：按應用分類的估計與趨勢分析

  • 細分儀表板
  • 按應用領域分類的趨勢分析和市場佔有率（2024 年和 2033 年）
  • 腫瘤學
  • 周邊血管疾病
  • 神經血管異常
  • 子宮肌瘤栓塞術
  • 創傷與出血控制
  • 其他

第6章：栓塞治療市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 2024 年和 2033 年按最終用途分類的變化分析和市場佔有率
  • 醫院和診所
  • 門診手術中心
  • 其他

第7章：栓塞治療市場：區域估計與趨勢分析

  • 區域展望
  • 2024年及2033年區域動態分析及市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Medtronic
    • Johnson &Johnson
    • B. Braun SE
    • Terumo
    • Boston Scientific Corporation
    • Meril
    • Gem srl
    • Balt
    • Sirtex（BlackSwan Vascular, Inc.）
    • INVAMED
    • Stryker
    • Penumbra
    • Merit Medical Systems
    • Abbott
    • Acandis GmbH
    • Cook Medical
Product Code: GVR-4-68040-763-5

Embolotherapy Market Summary

The global embolotherapy market size was estimated at USD 3.16 billion in 2024 and is projected to reach USD 5.82 billion by 2033, growing at a CAGR of 6.99% from 2025 to 2033. The market is primarily driven by the rising prevalence of cancer, vascular disorders, and trauma cases, which fuel demand for minimally invasive treatment options.

Technological advancements in embolic agents, such as drug-eluting beads, liquid embolic, and bioresorbable microspheres, along with innovative delivery devices like microcatheters and flow diverters, have improved procedural precision, safety, and clinical outcomes.

Moreover, increasing patient preference for less invasive procedures with shorter recovery times, expanding healthcare infrastructure in emerging markets, and supportive regulatory frameworks further accelerate adoption. Together, these factors create sustained growth opportunities and reinforce the market's upward trajectory.

The global rise in cancer treatments, trauma cases, and vascular disorders has amplified the need for advanced embolotherapy solutions. Hospitals, clinics, and interventional radiology centers are witnessing growing procedure volumes, creating continuous demand for effective embolic agents and delivery systems. This trend places additional pressure on healthcare facilities to adopt innovative, minimally invasive techniques that improve patient outcomes while maintaining safety and efficiency. To meet these needs, providers are increasingly turning to next-generation embolotherapy technologies that enable faster procedures, greater precision, and reduced complications.

For instance, in June 2025, Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) had cleared and launched the Ruby XL System, the longest, largest, and softest coil available on the market. The Ruby XL System is designed to enable physicians to perform more efficient embolizations, potentially decreasing radiation exposure and improving outcomes-particularly in procedures involving large vessels and high-flow embolizations.

The rising prevalence of cancer and vascular diseases is a major driver of the embolotherapy industry because these conditions often require targeted, minimally invasive treatments to control bleeding, reduce tumor size, or manage abnormal blood vessels. Patients with liver cancer frequently undergo transarterial embolization to block the blood supply to tumors, slowing their growth while preserving surrounding healthy tissue. Arteriovenous malformations or gastrointestinal bleeding cases are increasingly managed with embolotherapy, as it provides an effective alternative to open surgery with shorter recovery times and fewer complications. According to WHO, the estimated number of new cases of liver and intrahepatic bile duct cancers among both sexes (ages 0-85+) is projected to increase from 2022 to 2040, as shown in the data frame and illustrated in the graph below.

Global Embolotherapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global embolotherapy market report based on the product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Embolization Coils
    • Detachable Coils
    • Pushable Coils
  • Embolic Agents
    • Liquid Embolic Agents
    • Ethylene Vinyl Alcohol Copolymer (EVOH)
    • N-BCA (n-Butyl Cyanoacrylate)
    • N-HCA (n-Hexyl Cyanoacrylate)
    • Cyanoacrylates
    • Others
    • Microspheres
  • Flow Diverters
  • Detachable Balloons
  • Vascular Plugs/Plug Systems
  • Support Devices
    • Guidewires
    • Microcatheters
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
    • Liver Cancer (Hepatocellular carcinoma)
    • Renal Cell Carcinoma
    • Lung Cancer
    • Others
  • Peripheral Vascular Diseases
  • Neurovascular Abnormalities
  • Uterine Fibroid Embolization
  • Trauma and Bleeding Control
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End-Use
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
    • 1.9.1. Information or Data Analysis
    • 1.9.2. Data analysis models
    • 1.9.3. Market Formulation & Validation
    • 1.9.4. Model Details
  • 1.10. Commodity flow analysis (Model 1)
    • 1.10.1. Approach 1: Commodity flow approach
  • 1.11. Volume price analysis (Model 2)
    • 1.11.1. Approach 2: Volume price analysis
  • 1.12. List of Secondary Sources
  • 1.13. List of Primary Sources
  • 1.14. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Embolotherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of cancer and vascular diseases
      • 3.2.1.2. Technological advancements in embolic agents and devices
      • 3.2.1.3. Increasing trauma and hemorrhage cases
      • 3.2.1.4. Growing preference for minimally invasive procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of complications
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Development of novel embolic agents
      • 3.2.3.2. Rising adoption of minimally invasive procedures
      • 3.2.3.3. Expansion into emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. High cost of procedures and devices
  • 3.3. Embolotherapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Embolotherapy Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Embolotherapy Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Embolization Coils
    • 4.3.1. Embolization Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Detachable Coils
        • 4.3.1.1.1. Detachable Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Pushable Coils
        • 4.3.1.2.1. Pushable Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Embolic Agents
    • 4.4.1. Embolic Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Liquid Embolic Agents
        • 4.4.1.1.1. Ethylene Vinyl Alcohol Copolymer (EVOH) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.1. N-BCA (n-Butyl Cyanoacrylate)
          • 4.4.1.1.1.2. N-HCA (n-Hexyl Cyanoacrylate)
        • 4.4.1.1.2. Cyanoacrylates Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.3. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Microspheres
        • 4.4.1.2.1. Microspheres Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Flow Diverters
      • 4.4.2.1. Flow Diverters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Detachable Balloons
      • 4.4.3.1. Detachable Balloons Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Vascular Plugs/Plug Systems
      • 4.4.4.1. Vascular Plugs/Plug Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Support Devices
      • 4.4.5.1. Support Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.5.1.1. Guidewires
          • 4.4.5.1.1.1. Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.5.1.2. Microcatheters
          • 4.4.5.1.2.1. Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Embolotherapy Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Embolotherapy Market: Application Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Peripheral Vascular Diseases
    • 5.4.1. Peripheral Vascular Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Neurovascular Abnormalities
    • 5.5.1. Neurovascular Abnormalities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Uterine Fibroid Embolization
    • 5.6.1. Uterine Fibroid Embolization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Trauma and Bleeding Control
    • 5.7.1. Trauma and Bleeding Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Embolotherapy Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Embolotherapy Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals and Clinics
    • 6.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Embolotherapy Market: Regional Estimates & Trend Analysis by Product, Application, End Use

  • 7.1. Regional Outlook
  • 7.2. Embolotherapy Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Embolotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Johnson & Johnson
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. B. Braun SE
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Terumo
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Boston Scientific Corporation
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Meril
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Gem srl
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Balt
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Sirtex (BlackSwan Vascular, Inc.)
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiative
    • 8.2.10. INVAMED
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Stryker
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Penumbra
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Merit Medical Systems
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Abbott
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Acandis GmbH
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Cook Medical
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Product Benchmarking
      • 8.2.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global embolotherapy market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 10 US embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 11 US embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 12 US embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 25 UK embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 30 France embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 31 France embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 52 China embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 53 China embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 58 India embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 59 India embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA embolotherapy market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE embolotherapy market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait embolotherapy market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait embolotherapy market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait embolotherapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Embolotherapy market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Embolotherapy market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Embolization coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Detachable coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Pushable coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Liquid embolic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Ethylene vinyl alcohol copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 N-butyl cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 N-hexyl cyanoacrylate market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Cyanoacrylates market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Flow diverters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Detachable balloons market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Vascular plugs/plug systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Support devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Microcatheters systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Liver cancer (hepatocellular carcinoma) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Renal cell carcinoma market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Lung cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Peripheral Vascular Diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Neurovascular abnormalities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Uterine fibroid embolization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Trauma and bleeding control market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Ambulatory surgical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Other end-use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Embolotherapy market: Regional key takeaways (USD Million)
  • Fig. 44 Embolotherapy market: Regional outlook, 2024 & 2033, USD Million
  • Fig. 45 North America embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 US embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Canada embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Europe embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 UK embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Germany embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 France embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Spain embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Sweden embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Norway embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Japan embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 India embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Australia embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Middle East and Africa embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 UAE embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait embolotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 List of key emerging companies
  • Fig. 74 Company market share analysis, 2024
  • Fig. 75 Market differentiators
  • Fig. 76 Competitive dashboard analysis
  • Fig. 77 Regional network map